Author

Bjoern Mellgard

Observed name: B. Mellgard

Institution: Shire (Switzerland)

Observed institutions: Shire (Switzerland), Novartis Institutes for BioMedical Research

OpenAlex ID: A5076848290

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

2012 · Wolfgang Hueber, Bruce E Sands, et al. · Gut · 1,545

Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study

2016 · P. B. Miner, M. Camilleri, et al. · Neurogastroenterology & Motility · 32

Works count: 2

Citation count: 1,577

H-index: 2

I10-index: 2